Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease

Molecular Psychiatry volume 9, pages 371–385 (2004)Cite this article

Abstract

We assessed the ability of lithium to reduce neurodegeneration and to stimulate cell proliferation in a rat model of Huntington's disease in which quinolinic acid (QA) was unilaterally infused into the striatum. LiCl (0.5–3.0 mEq/kg) was injected subcutaneously 24 h before and 1 h after QA infusion. At 7 days after QA injection, lithium significantly diminished the loss of neurons immunostained for Neuronal Nuclei (NeuN) in the injured striatum, but failed to prevent the reduction of NADPH-diaphorase-positive striatal interneurons. Lithium also reduced the number of neurons showing DNA damage or activated caspase-3. This neuroprotection was associated with an upregulation of Bcl-2 protein levels in the striatal tissue and an increase in the number and density of Bcl-2 immunostaining in striatal neurons. Bromodeoxyuridinie (BrdU) labeling in the lithium-treated injured striatum revealed the presence of large numbers of proliferating cells near the QA-injection site, with a reduction of BrdU-labeled cells in the subventricular zone (SVZ). All BrdU-labeled cells in the SVZ and the majority of BrdU-labeled cells near the QA-injection site were negative for either NeuN or glial fibrillary acidic protein (GFAP), suggesting that they are undifferentiated progenitor cells. However, a small number of BrdU-positive cells found in the QA-injected and lithium-treated striatum site were positive for either NeuN or GFAP. Our results suggest that lithium is neuroprotective in the QA-injection model of Huntington's disease not only due to its ability to inhibit apoptosis but also because it can stimulate neuronal and astroglial progenitor proliferation in the QA-injected striatum or their migration from the SVZ.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12

References

  1. Mitchell IJ, Cooper AJ, Griffiths MR . The selective vulnerability of striatopallidal neurons. Prog Neurobiol 1999; 59: 691–719.

    Article  CAS  Google Scholar 

  2. Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S . Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci 2001; 24: 182–188.

    Article  CAS  Google Scholar 

  3. Schwarcz R, Pellicciari R . Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 2002; 303: 1–10.

    Article  CAS  Google Scholar 

  4. Schwarcz R, Whetsell WO, Mangano RM . Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983; 219: 316–318.

    Article  CAS  Google Scholar 

  5. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB . Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 1986; 321: 168–171.

    Article  CAS  Google Scholar 

  6. Beal MF, Ferrante RJ, Swartz KJ, Kowall NW . Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J Neurosci 1991; 11: 1649–1659.

    Article  CAS  Google Scholar 

  7. Qin ZH, Chen RW, Wang Y, Nakai M, Chuang D-M, Chase TN . Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J Neurosci 1999; 19: 4023–4033.

    Article  CAS  Google Scholar 

  8. Ferrante RJ, Kowall NW, Cipolloni PB, Storey E, Beal MF . Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp Neurol 1993; 119: 46–71.

    Article  CAS  Google Scholar 

  9. Storey E, Cipolloni PB, Ferrante RJ, Kowall NW, Beal MF . Movement disorder following excitotoxin lesions in primates. Neuroreport 1994; 5: 1259–1261.

    Article  CAS  Google Scholar 

  10. Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME et al. Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J Neurosci Res 1999; 58: 515–532.

    Article  CAS  Google Scholar 

  11. Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P et al. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 2002; 33: 849–860.

    Article  CAS  Google Scholar 

  12. Taylor-Robinson SD, Weeks RA, Bryant DJ, Sargentoni J, Marcus CD, Harding AE et al. Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory. Mov Disord 1996; 11: 167–173.

    Article  CAS  Google Scholar 

  13. Metman LV, Morris MJ, Farmer C, Gillespie M, Mosby K, Wuu J et al. Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine. Neurology 2002; 59: 694–699.

    Article  CAS  Google Scholar 

  14. Nonaka S, Hough CJ, Chuang D-M . Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 1998; 95: 2642–2647.

    Article  CAS  Google Scholar 

  15. Hashimoto R, Hough C, Nakazawa T, Yamamoto T, Chuang D-M . Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem 2002; 80: 589–597.

    Article  CAS  Google Scholar 

  16. Hashimoto R, Takei N, Shimazu K, Christ L, Lu B, Chuang D-M . Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology 2002; 43: 1173–1179.

    Article  CAS  Google Scholar 

  17. Hashimoto R, Fujimaki K, Jeong MR, Christ L, Chuang D-M . Lithium-induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in neuroprotection against N-methyl-D-aspartate receptor-mediated excitotoxicity. FEBS Lett 2003; 538: 145–148.

    Article  CAS  Google Scholar 

  18. Nonaka S, Chuang D-M . Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 1998; 9: 2081–2084.

    Article  CAS  Google Scholar 

  19. Ren M, Senatorov VV, Chen R-W, Chuang D-M . Post-insult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Natl Acad Sci USA 2003; 10: 6210–6215.

    Article  Google Scholar 

  20. Chuang D-M, Chen RW, Chalecka-Franaszek E, Ren M, Hashimoto R, Senatorov V et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 2002; 4: 129–136.

    Article  CAS  Google Scholar 

  21. Grimes CA, Jope RS . The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2002; 65: 391–426.

    Article  Google Scholar 

  22. Wei H, Qin ZH, Senatorov VV, Wei W, Wang Y, Qian Y et al. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience 2001; 106: 603–612.

    Article  CAS  Google Scholar 

  23. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK . Enhancement of hippocampal neurogenesis by lithium. J Neurochem 2000; 75: 1729–1734.

    Article  CAS  Google Scholar 

  24. Cui H, Meng Y, Bulleit RF . Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells. Dev Brain Res 1998; 111: 177–188.

    Article  CAS  Google Scholar 

  25. Hashimoto R, Senatorov VV, Kanai H, Leeds P, Chuang D-M . Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience 2003; 117: 55–61.

    Article  CAS  Google Scholar 

  26. Ikeda M, Kanai H, Akaike M, Tsutsumi S, Sadamatsu M, Masui A et al. Nitric oxide synthase-containing neurons in the hippocampus are preserved in trimethyltin intoxication. Brain Res 1996; 712: 168–170.

    Article  CAS  Google Scholar 

  27. Abercrombie M . Estimation of nuclear population from microtome sections. Anat Rec 1946; 94: 239–247.

    Article  CAS  Google Scholar 

  28. Nakai M, Qin ZH, Wang Y, Chase TN . Free radical scavenger OPC-14117 attenuates quinolinic acid-induced NF-kappaB activation and apoptosis in rat striatum. Mol Brain Res 1999; 64: 59–68.

    Article  CAS  Google Scholar 

  29. Mullen RJ, Buck CR, Smith AM . NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992; 116: 201–211.

    CAS  PubMed  Google Scholar 

  30. Yuan J, Yankner BA . Apoptosis in the nervous system. Nature 2000; 407: 802–829.

    Article  CAS  Google Scholar 

  31. Davies SW, Roberts PJ . No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid. Nature 1987; 327: 326–329.

    Article  CAS  Google Scholar 

  32. Koh JY, Choi DW . Cultured striatal neurons containing NADPH-diaphorase or acetylcholinesterase are selectively resistant to injury by NMDA receptor agonists. Brain Res 1988; 446: 374–378.

    Article  CAS  Google Scholar 

  33. Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K . Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Br J Pharmacol 1998; 124: 391–399.

    Article  CAS  Google Scholar 

  34. Kalisch BE, Jhamandas K, Beninger RJ, Boegman RJ . Modulation of quinolinic acid-induced depletion of striatal NADPH diaphorase and enkephalinergic neurons by inhibition of nitric oxide synthase. Brain Res 1999; 817: 151–162.

    Article  CAS  Google Scholar 

  35. Regulier E, Pereira de Almeida L, Sommer B, Aebischer P, Deglon N . Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum Gene Ther 2002; 13: 1981–1990.

    Article  CAS  Google Scholar 

  36. Kang SH, Kim DY, Gwag BJ . Reduced expression of caspase-9 underlying selective sparing of striatal neurons containing NADPH diaphorase against apoptosis. Abst Soc Neurosci 2002; 293.15.

  37. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE . Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J Neurosci 1995; 15: 3775–3787.

    Article  CAS  Google Scholar 

  38. Werth JL, Park TS, Silbergeld DL, Rothman SM . Excitotoxic swelling occurs in oxygen and glucose deprived human cortical slices. Brain Res 1998; 782: 248–254.

    Article  CAS  Google Scholar 

  39. Dempsey RJ, Baskaya MK, Dogan A . Attenuation of brain edema, blood–brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats. Neurosurgery 2000; 2: 399–406.

    Article  Google Scholar 

  40. Stover JF, Unterberg AW . Increased cerebrospinal fluid glutamate and taurine concentrations are associated with traumatic brain edema formation in rats. Brain Res 2000; 875: 51–55.

    Article  CAS  Google Scholar 

  41. Stadelmann C, Lassmann H . Detection of apoptosis in tissue sections. Cell Tissue Res 2000; 301: 19–31.

    Article  CAS  Google Scholar 

  42. Sanchez Mejia RO, Friedlander RM . Caspases in Huntington's disease. Neuroscientist 2001; 7: 480–489.

    Article  CAS  Google Scholar 

  43. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996; 184: 1331–1341.

    Article  CAS  Google Scholar 

  44. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD . The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132–1136.

    Article  CAS  Google Scholar 

  45. Malberg JE, Eisch AJ, Nestler EJ, Duman RS . Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104–9110.

    Article  CAS  Google Scholar 

  46. Alvarez-Buylla A, Garcia-Verdugo JM . Neurogenesis in adult subventricular zone. J Neurosci 2002; 22: 629–634.

    Article  CAS  Google Scholar 

  47. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S . Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology 2001; 158: 100–106.

    Article  CAS  Google Scholar 

  48. Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T . Brain-derived neurotrophic factor in Huntington's disease. Brain Res 2000; 866: 257–261.

    Article  CAS  Google Scholar 

  49. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001; 293: 493–498.

    Article  CAS  Google Scholar 

  50. Pencea V, Bingaman KD, Wiegand SJ, Luskin MB . Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci 2001; 21: 6706–6717.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Christopher Hough and Peter Leeds for their editorial assistance and constructive comments.

Author information

Author notes

  1. V V Senatorov

    Present address: National Eye Institute, NIH, Bethesda, MD, USA

Authors and Affiliations

  1. Molecular Neurobiology Section, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA

    V V Senatorov, M Ren, H Kanai, H Wei & D-M Chuang

Authors
  1. V V Senatorov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Kanai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D-M Chuang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D-M Chuang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Senatorov, V., Ren, M., Kanai, H. et al. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease. Mol Psychiatry 9, 371–385 (2004). https://doi.org/10.1038/sj.mp.4001463

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001463

Keywords

  • lithium
  • striatum
  • quinolinic acid
  • apoptosis
  • proliferation
  • Bcl-2

This article is cited by

Search

Advanced search

Quick links